Fig. 1From: Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case reportClinical course of patient’s disease: time line of diagnoses and tumor staging, begin of treatment initiation (yellow block: polychemotherapy, red block: anti-tumor peptide vaccine) and time points of immune monitoringBack to article page